Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 2 days, and 1 more · Every feed →

All 9Congress 3Executive branch 0Insiders 6
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

NTLA · 9 trades

Trades
9
Buys 2 · Sells 7
People
5
Stocks
1
Disclosed value
$603K
range midpoints · Congress & executive
Filed late
1
  1. ▼ SELLMichael P Dube VP, Chief Accounting OfficerNTLA Intellia Therapeutics, Inc.$23.2Kdisclosed Oct 6 · filed 4 days after the trade
  2. ▼ SELLJohn M Leonard President and CEONTLA Intellia Therapeutics, Inc.$251Kdisclosed Aug 24 · filed 4 days after the trade
  3. ▼ SELLJohn M Leonard President and CEONTLA Intellia Therapeutics, Inc.$36.2Kdisclosed Aug 24 · filed 3 days after the trade
  4. ▼ SELLEdward J Dulac III EVP, Chief Financial OfficerNTLA Intellia Therapeutics, Inc.$91.2Kdisclosed Jul 24 · filed 2 days after the trade
  5. ▼ SELLMichael P Dube VP, Chief Accounting OfficerNTLA Intellia Therapeutics, Inc.$44.3Kdisclosed Jul 6 · filed 5 days after the trade · late
  6. ▼ SELLEdward J Dulac III EVP, Chief Financial OfficerNTLA Intellia Therapeutics, Inc.$84.2Kdisclosed Jul 6 · filed 4 days after the trade
  7. ▲ BUYThomas R. Carper Dem · Senate · DENTLA Intellia Therapeutics, Inc.$1K–$15Kdisclosed Dec 25, 2020 · filed 35 days after the trade
  8. ▼ SELLJames M. Inhofe Rep · Senate · OKNTLA Intellia Therapeutics, Inc.$15K–$50Kdisclosed Nov 29, 2018 · filed 35 days after the trade
  9. ▲ BUYJames M. Inhofe Rep · Senate · OKNTLA Intellia Therapeutics, Inc.$15K–$50Kdisclosed Nov 23, 2017 · filed 35 days after the trade